May 11, 2020
Soligenix Announces Publication of Correlates of Immune Protection for the RiVax® Ricin Toxin Vaccine
Apr 28, 2020
PathSensors, Inc Announced a New Air Sampling Invention
Apr 21, 2020
Global Biodefense Market is Expected to Reach $8.85 Billion by 2027
Mar 25, 2020
2020 Virology & Bacteriology Industry Insights - The Threat of Bioterrorism is Among the Main Driving Forces
Feb 13, 2020
FDA Grants Soligenix "Fast Track" Designation for RiVax® in the Prevention of Ricin Poisoning
Dec 12, 2019
Soligenix Initiates Clinical Trial of its Heat Stable Ricin Toxin Vaccine
Jun 13, 2019
Soligenix to Present RiVax® Program at the 13 Annual CounterACT Network Research Symposium
May 29, 2019
BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent
Apr 15, 2019
Zeteo Tech Awarded $6.5M DHS S&T Contract to Develop and Test digitalMALDI(TM) Real-Time Biological Threat Detection Technology
Dec 14, 2018
The Global Market for Anthrax Treatment (2019-2023) - Bayer, Elusys Therapeutics and Emergent BioSolutions are the Leading Players
Nov 12, 2018
Soligenix Selected to Present RiVax® Data at the Fourth International Conference on Vaccines Research & Development in Baltimore, Maryland
Oct 03, 2018
Ricin suspected in mail sent to Trump, Pentagon
Oct 02, 2018
Ricin suspected in mail sent to White House, Pentagon
Sep 04, 2018
Soligenix Announces Publication of Positive Long-Term Data Supporting Thermostability and Conformational Integrity of the RiVax® Ricin Toxin Vaccine
Aug 07, 2018
Global Biodefense Market Analysis, Growth, Trends & Forecast 2018-2023, With an Expected CAGR of 6.5% - ResearchAndMarkets.com
Jul 26, 2018
Soligenix Announces a RiVax® Program Presentation at the 31st Annual Congress on Vaccines, Clinical Trials & B2B in Vancouver, Canada
Jul 09, 2018
Soligenix Receives European and Canadian Patents for its Ricin Toxin Vaccine (RiVax®) Formulation
Mar 15, 2018
Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results
Jan 09, 2018
Appili Therapeutics Licenses Bioterrorism Vaccine Rights
Dec 21, 2017
Soligenix Identifies Biomarkers for Ricin Toxin Vaccine Testing under the FDA Animal Rule